Highest-materiality recent filing
Net sales $376M (+11% YoY, +18% QoQ); loss from continuing ops $33M vs $81M in Q1 and $366M in prior-year Q2 (which included $337M deferred tax write-off).
Rayonier Advanced Materials General Counsel R. Colby Slaughter resigns effective Aug 7, 2026
R. Colby Slaughter, SVP, General Counsel and Corporate Secretary, notified resignation on July 20, 2026.
Daniel M. Krawczyk named CEO; Board continues strategic alternatives review with Morgan Stanley
Daniel M. Krawczyk appointed CEO and President, effective June 22, 2026; also joins Board as Class III director.
RYAM shareholders elect two directors but reject board declassification and supermajority repeal
Charles R. Eggert and David C. Mariano elected to board, terms expiring 2029.
Julie A. Dill elected Non-Executive Chair of RYAM Board, succeeding Lisa M. Palumbo
Effective May 14, 2026; Palumbo completed her second two-year term and remains an independent director.
RYAM Q1 net loss $81M ($1.22/sh), adjusted EBITDA $8M; strategic review underway
Net sales $319M, down 10% YoY from $353M; net loss $81M vs loss $32M prior year, including $41M non-cash idling charge.
Director Scott M. Sutton resigns from RYAM Board, withdraws as nominee
Scott M. Sutton resigned from the Board of Directors on April 24, 2026.
RYAM CEO resigns; board launches strategic alternatives review with Morgan Stanley
CEO Scott M. Sutton resigned effective April 16, 2026.
RYAM Q4 2025 loss $21M, sales $417M; full-year Adj EBITDA $133M, negative FCF $88M
Q4 loss from continuing ops $21M ($0.32 diluted EPS) vs loss $16M in prior year; net sales $417M, down $5M.
Rayonier Advanced Materials abandons Altamaha Green Energy project
Company will not advance participation in the Altamaha Green Energy project after comprehensive review.
Rayonier Advanced Materials SVP High Purity Cellulose Joshua Hicks departs
Joshua Hicks, SVP High Purity Cellulose, separated from RYAM effective Jan 11, 2026.
Rayonier Advanced Materials appoints Scott Sutton as CEO, effective Jan 5, 2026
Scott Sutton, former Olin CEO, succeeds DeLyle Bloomquist who steps down as CEO and board member.
RYAM CEO De Lyle W. Bloomquist to retire by May 2026; board launches search
President and CEO De Lyle W. Bloomquist to retire by May 2026 annual meeting; will remain until successor named.
RYAM Q3 net loss narrows to $4M; FY2025 Adjusted EBITDA guided $135-140M
Q3 net sales $353M (-$48M YoY); loss from cont ops $4M vs $33M loss YoY.
Rayonier Advanced Materials appoints Jared Rollins as CAO, replacing Gabriela Garcia
Gabriela Garcia resigns as CAO and VP Corporate Controller effective Oct 10, 2025; no disagreement with company.
RYAM and USW file antidumping petitions on Brazil and Norway HPDP imports
Petitions allege HPDP dumping margins up to 168% (Brazil) and 226% (Norway); 30 Brazilian subsidy programs cited.
RYAM Q2 net loss $363M on $337M DTA write-off; cuts 2025 EBITDA guidance to $150-160M
Net loss of $363M ($5.44/diluted share) vs. prior-year income of $11M; includes $337M non-cash Canadian deferred tax asset write-off.
Lisa M. Palumbo, Ivona Smith, and Bryan D. Yokley elected to board for terms expiring 2028.
RYAM reports Q1 net loss $32M; lowers FY 2025 Adj. EBITDA guidance to $175-185M
Net loss $32M ($0.49/diluted share) vs net loss $2M prior year; revenue $356M down 8% YoY.
RYAM 2024 adj. EBITDA $222M (+60% YoY); guides 2025 $215-235M
Net sales $1,630M (-$13M YoY); loss from cont. ops $42M vs $102M loss prior year.
RYAM reports preliminary FY2024: Adj. EBITDA $222M (+60%); tariff impact up to $3.5M/month
Net sales $1,639M (flat YoY); loss from cont. ops $43M, improved $59M.
RYAM raises €67M green capital for BioNova subsidiary; targets $40M+ EBITDA by 2027
€37M secured term loans from Crédit Lyonnais, Arkéa Banque, BNP Paribas at ~5% floating rate, ~7-year maturity.
RYAM closes $700M term loan, repays existing debt, extends ABL to 2029
Borrowed $700M under new senior secured term loan facility to refinance existing debt and redeem 7.625% 2026 Notes.
RYAM consummates cash tender offer for $135.5M of its 7.625% Senior Secured Notes due 2026
Accepted $135,486,000 aggregate principal (29.93% of outstanding notes) validly tendered; payment made Nov 7, 2024.
RYAM Q3 net loss $33M on impairment; reiterates EBITDA, ups FCF guidance; $700M refinancing
Q3 net loss $33M ($0.49/diluted) vs $25M loss last year; includes $25M asset impairment and $7M suspension charges.
RYAM subsidiary commences cash tender offer for $452.6M in 7.625% Secured Notes due 2026
Issuer Rayonier A.M. Products offers to purchase any and all of its $452.6M 7.625% Senior Secured Notes due 2026 at par plus accrued interest.
RYAM closes $700M secured term loan to refinance 2026 notes and existing debt
$700M senior secured term loan from Oaktree, Silver Point, Blue Torch; interest = 3M Term SOFR + 7.00%.
RYAM elects Eric M. Bowen to board; Charles Adair resigns for personal reasons
Charles E. Adair resigned from RYAM board effective Sept 8, 2024, for personal reasons, no disagreement.
RYAM Q2 net income $11M vs loss; raises 2024 EBITDA outlook to $205-215M
Net income $11M ($0.17/diluted) vs net loss of $17M (-$0.26) in Q2 2023; revenue $419M, up $34M.
All three director nominees (Adair, Dill, Kirsch) elected with 41-44M votes for; ~8M broker non-votes.
RYAM Reports Q1 Net Loss $2M, Adj EBITDA $52M; Raises 2024 FCF Guidance
Net loss $2M ($0.02/diluted share) vs net income $2M in prior year; revenue $388M, down $79M YoY.
Indefinite suspension of Temiscaming HPC plant due to market weakness and high costs.
RYAM reports 2023 loss of $102M; guides 2024 Adjusted EBITDA $180-200M
Net sales $1,643M (-$74M YoY); loss from continuing ops $102M (incl. $62M non-cash impairment) vs. loss $27M prior year.
RYAM amends term loan credit agreement for financial covenant relief through FY 2024
Amendment increases max consolidated secured net leverage ratio to 5.25x for Q4 2023 through Q2 2024.
RYAM Q3 loss from continuing ops $27M; cuts 2023 EBITDA guidance to ~$150M, raises FCF to $65-75M
Q3 loss from continuing ops $27M ($0.41/sh) vs. prior-year income $18M ($0.28/sh).
Director Thomas I. Morgan resigns; Bryan D. Yokley elected to RYAM board
Thomas I. Morgan resigned effective September 30, 2023, for personal reasons; no disagreement with company operations.
RYAM Q2 loss narrows to $16M; lowers EBITDA guidance, raises FCF outlook
Net loss from continuing ops $16M ($0.24/share) vs $25M loss a year ago; adjusted EBITDA $27M, down 21% YoY.
RYAM secures $250M Oaktree loan to refinance $318M 2024 notes, matures 2027
$250M term loan from Oaktree at 3-month SOFR (3% floor) +8.00%, matures July 20, 2027.
RYAM is in active negotiations to refinance its 5.5% senior unsecured notes maturing June 2024.
All three director nominees (Bloomquist, Eggert, Mariano) elected to three-year terms expiring 2026.
RYAM Q1 net income $2M vs loss; raises FCF guidance to $40-65M
Net sales $467M (+33% YoY); Adj EBITDA $51M (+155% YoY); net income $2M vs loss $25M.
RYAM hires Michael Osborne as VP, Manufacturing; Bill Manzer to retire in 2024
Michael Osborne joined as VP, Manufacturing on April 10, replacing Bill Manzer who will retire.
RYAM EVP Manufacturing retiring; replacement named
William R. Manzer to retire as EVP Manufacturing Operations effective May 31, 2023.
RYAM Q4 net income $4M vs loss $24M; guides 2023 Adj. EBITDA $200-215M
Q4 net sales $500M (+34% YoY); income from cont. ops $4M vs loss $28M prior year.
RYAM prelim Q4 revenue $488-508M, adj EBITDA $52-56M; full-year loss $28-32M
Q4 2022 revenue estimated $488-508M; income (loss) from continuing ops ($1M) to $3M.
RYAM commences $325M senior secured notes offering to redeem 2024 notes
Rayonier A.M. Products Inc. offers $325M aggregate principal of senior secured notes due 2028 in private placement.
RYAM Q3 swings to profit; Adj EBITDA $68M, up 106%; raises FY22 guidance to >$175M
Net sales $466M (+25% YoY); net income $30M ($0.45/diluted) vs net loss of $5M
RYAM elects Charles R. Eggert to board; board size reduced to 9
Charles R. Eggert elected as Class III independent director, effective October 19, 2022.
Rayonier Advanced Materials amends bylaws to adopt universal proxy rules
Board approved bylaw amendments effective Oct 19, 2022 to comply with SEC universal proxy rules.
RYAM Q2 net loss $25M, revenue $399M (+17% YoY); FY Adj EBITDA guidance >$160M
Net loss from continuing ops $25M (-$0.39/diluted) vs income of $8M a year ago; total net loss $23M (-$0.36/diluted).
Effective June 22, 2026, t he Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (“RYAM” or the “Company”) appointed Daniel M. Krawczyk as Chief Executive Officer and President of the Company.
Effective at the same time, the Board also appointed Mr. Krawczyk to serve as a Class III director of the Board, with a term expiring at the Company’s 2029 annual meeting of stockholders, thereby filling the existing vacancy on the Board.
Effective September 9, 2024, the Company’s Board elected Eric M. Bowen as a Class I independent director of the Company to serve until the 2027 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.
Charles E. Adair tendered his resignation from the Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (the “Company”) effective 11:59 p.m. (EDT) on September 8, 2024.
Effective October 1, 2023, the Company’s Board elected Bryan D. Yokley as a Class II independent director of the Company to serve until the 2025 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.
Thomas I. Morgan tendered his resignation from the Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (the “Company”) effective 5:00 p.m. (EDT) on September 30, 2023.
William R. Manzer informed management of his intention to retire as Executive Vice President, Manufacturing Operations of the Company, effective at 11:59 p.m. on May 31, 2023.
elected Charles R. Eggert as a Class III independent director of the Company
On May 28, 2022, the Board of Directors (the “ Board ”) of Rayonier Advanced Materials Inc. (the “ Company ”) appointed De Lyle W. Bloomquist as President and Chief Executive Officer of the Company.
Mr. Bloomquist succeeds Vito J. Consiglio, who stepped down as President and Chief Executive Officer of the Company with the mutual agreement of the Board on the same day.
The Board named Lisa M. Palumbo as Non-Executive Chair of the Board.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Max materiality 0.85 · Median 0.70 · Most common event earnings